Recent research has overturned the idea that self-critical behavior fosters resilience. An innovative study demonstrated that ...
Qure may seek approval in the UK first while in talks with the FDA about its request for a larger, sham-controlled trial of ...
The first patient was treated at Monash Health in Clayton, Victoria, Australia, with other trial sites planned in the near future.
Well before the term “personalized medicine” first appeared, the notion of healthcare tailored to the individual loomed on ...
About 60% of IVF attempts fail. Fertility clinics offer a long list of tests and procedures purported to boost their ...
Vivani CEO Adam Mendelsohn, Ph.D., stated, “HREC approval to initiate SLIM-1 in Australia marks an important moment for our Company, clearing the way for near-term, mid-2026, initiation. We are eager ...
For more than 10 years, the stroke research community has sought and investigated drugs that could enhance or strengthen the ...
Background Nearly half of all 4.8 million annual paediatric deaths worldwide are caused by acute illnesses, which are ...
The US Food and Drug Administration (FDA) roadmap to reduce animal testing as a requirement for drug development has already made an impact after its first year, but the initiative faces future ...
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical ...
(NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCE ® (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the ...
Sjögren’s disease (SjD) is a chronic, multisystem autoimmune disorder characterised by lymphocytic infiltration of exocrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results